In a latest article in Scientific Studies, researchers examined using single-layer graphene oxide (slGO) nanosheets to boost the proliferation and osteogenic differentiation of human bone marrow stem cells (hBMSCs) when encapsulated in alginate microgels. Integrating slGO right into a microfluidic system goals to create a conducive three-dimensional (3D) setting that mimics pure tissue circumstances, thereby selling cell development and performance.
Picture Credit score: alicancomertpay/Shutterstock.com
Background
Graphene oxide has develop into outstanding in biomedical purposes on account of its excessive floor space, mechanical power, and biocompatibility. Earlier research recommend that graphene oxide’s dimension and floor properties considerably affect stem cell habits, particularly in selling differentiation into osteoblasts. Controlling these properties permits tailor-made purposes in regenerative drugs.
Microfluidic cell encapsulation presents benefits like exact droplet management, which is important for cell viability and nutrient change. This research expands on current data by investigating the mixed results of slGO and alginate microgels on hBMSCs to enhance osteogenic potential.
The Present Examine
The researchers employed numerous methods to characterize slGO and analyze its results on hBMSCs. Fourier rework infrared (FTIR) spectroscopy was utilized to establish practical teams in slGO, whereas atomic drive microscopy (AFM) and scanning electron microscopy (SEM) have been employed to look at the floor morphology and topography of the nanosheets. The dimensions distribution and zeta potential of slGO have been measured utilizing a Zetasizer Nano ZS95, making certain that the nanosheets have been throughout the optimum dimension vary for organic purposes.
To guage the cytotoxicity of slGO, an MTT assay was carried out on hBMSCs uncovered to various concentrations of slGO over totally different time intervals. The metabolic exercise of the cells was quantified to find out the influence of slGO on cell viability. Moreover, the encapsulation of hBMSCs in alginate microgels was achieved utilizing a microfluidic machine, which facilitated the era of uniform droplets.
The encapsulated cells have been subjected to reside/lifeless assays to evaluate their viability over time. Moreover, quantitative reverse transcription polymerase chain response (qRT-PCR) was carried out to research the expression ranges of osteogenic marker genes, together with Runx2, alkaline phosphatase (ALP), and osteocalcin (OCN), offering insights into the differentiation standing of the hBMSCs.
Outcomes and Dialogue
The slGO nanosheets exhibited a dimension of roughly 916.9 nm after sonication, which was favorable for stem cell differentiation. The zeta potential of -18.7 mV indicated good stability of the slGO suspension.
MTT assay outcomes confirmed that low slGO concentrations (0.002 to 0.2 μg/mL) didn’t considerably have an effect on cell viability, whereas increased concentrations (2 and 20 μg/mL) led to a notable lower in hBMSC proliferation after 48 hours. This means that slGO is biocompatible at low doses however can develop into cytotoxic at increased ranges, according to prior research on nanomaterial dosage results.
Encapsulation of hBMSCs in alginate microgels supported cell survival and proliferation, as proven by reside/lifeless assays indicating excessive viability. qRT-PCR evaluation revealed considerably elevated expression of osteogenic markers in slGO-encapsulated hBMSCs in comparison with controls, with enhanced ranges of Runx2, ALP, and OCN. These findings point out that slGO not solely helps cell viability but in addition promotes osteogenic differentiation. These findings point out slGO’s potential as a bioactive element in bone tissue engineering scaffolds, enhancing each cell survival and differentiation.
The research additionally emphasizes the significance of microfluidics in reaching uniform cell encapsulation, essential for constant cell responses. Integrating slGO into alginate microgels inside a microfluidic system presents an modern strategy to growing biomaterials for regenerative drugs. This methodology permits for fine-tuning microgel properties by way of slGO incorporation, presenting alternatives for optimized stem cell therapies.
Conclusion
This research demonstrates that slGO nanosheets can improve the proliferation and osteogenic differentiation of hBMSCs when encapsulated in alginate microgels. The outcomes assist slGO’s biocompatibility at low concentrations and its potential function as a bioactive element in tissue engineering. The microfluidic encapsulation methodology additional refines this strategy, enabling exact management over the mobile microenvironment.
These findings contribute to the rising understanding of nanomaterials in regenerative drugs and spotlight slGO’s potential as a candidate for superior scaffolds supporting stem cell perform and tissue regeneration. Future analysis ought to give attention to optimizing formulations and assessing long-term in vivo results to completely notice slGO’s therapeutic potential.
Journal Reference
Soleymani H., et al. (2024). Single-layer graphene oxide nanosheets induce proliferation and Osteogenesis of single-cell hBMSCs encapsulated in Alginate Microgels. Scientific Studies 14, 25272. DOI: 10.1038/s41598-024-76957-y, https://www.nature.com/articles/s41598-024-76957-y
